[SIADH and vaptans].
Copyright policy )[SIADH and vaptans].
The vaptans are non-peptide arginine-vasopressin-receptor antagonists, that are orally and intravenously active. A few vaptans have undergone sufficient clinical development to be on the market. In the EU only tolvaptan is accepted to treat hyponatremia related to SIADH. The place of this new treatment is compared with water restriction, demeclocyclin, furosemide and urea.
- Erasmus Hospital Belgium
Inappropriate ADH Syndrome, Demeclocycline, Hormone Antagonists, Tolvaptan, Humans, Benzazepines, Lithium, Models, Biological, Antidiuretic Hormone Receptor Antagonists, Anti-Bacterial Agents, Antipsychotic Agents
Inappropriate ADH Syndrome, Demeclocycline, Hormone Antagonists, Tolvaptan, Humans, Benzazepines, Lithium, Models, Biological, Antidiuretic Hormone Receptor Antagonists, Anti-Bacterial Agents, Antipsychotic Agents
selected citations These citations are derived from selected sources.This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).2 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Average influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Average impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Average
Citations provided by BIP!Popularity provided by BIP!